Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor-and growth factor-signaling pathways

Molecular Nutrition and Food Research

Volumn 54, Issue 3, 2010, Pages 415-425

  Saggar, Jasdeep Kaur ^a   Chen, Jianmin ^a   Corey, Paul ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Flaxseed; Growth factor signaling; Lignan; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; BUTANEDIOL; ESTROGEN RECEPTOR; GLUCOSIDE; GROWTH FACTOR RECEPTOR; LIGNAN; LINSEED OIL; MESSENGER RNA; SECOISOLARICIRESINOL DIGLUCOSIDE; TAMOXIFEN; TUMOR MARKER;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; FLAX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYTOTHERAPY; PLANT SEED; RANDOMIZATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; BUTYLENE GLYCOLS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLAX; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSIDES; HUMANS; LIGNANS; LINSEED OIL; MICE; MICE, NUDE; PHYTOTHERAPY; RANDOM ALLOCATION; RECEPTORS, ESTROGEN; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; SEEDS; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; LOTUS; MUS; MUS MUSCULUS;

EID: 77649281088     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900068     Document Type: Article

References (43)

1. Fabian, C. J., Kimler, B. F., Chemoprevention for high-risk women: tamoxifen and beyond. Breast J. 2001, 7, 311-320.
2. Ring, A., Dowsett, M., Mechanisms of tamoxifen resistance. Endocr. Relat. Cancer 2004, 11, 643-658.
3. Gruber, C. J., Tschugguel, W., Schneeberger, C., Huber, J. C., Production and actions of estrogens. N. Engl. J. Med. 2002,346,340-352.
4. Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E. et al., Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer Inst. 2004, 96, 926-935.
5. Thompson, L. U., Ward, W. E., in: Gilani, S. C., Anderson, J. (Eds.), Phytoestrogens and Human Health, AOCS Press, Champaign, IL 2002, pp. 405-426.
6. Thompson, L. U., Robb, P., Serraino, M., Cheung, F., Mammalian lignan production from various foods. Nutr. Cancer 1991, 16, 43-52.
7. Adlercreutz, H., Phyto-oestrogens and cancer. Lancet Oncol. 2002,3,364-373.
8. Power, K. A., Thompson, L. U., Flaxseed and lignans: effects on breast cancer, in: Awad, A., Bradford, P. G. (Eds.), Nutrition and Cancer Prevention, CRC Press, Boca Raton, FL 2006, pp. 385-410.
9. Chen, J., Hui, E., Ip, T., Thompson, L. U., Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin. Cancer Res. 2004, 10, 7703-7711.
10. Chen, J., Power, K. A., Mann, J., Cheng, A., Thompson, L. U., Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. (Maywood) 2007b, 232, 1071-1080.
11. Chen, J., Power, K. A., Mann, J., Cheng, A., Thompson, L. U., Dietary flaxseed interaction with tamoxifen induced tumor regression in nude mice with MCF-7 xenografts by down-regulating the expression of estrogen related gene products and signal transduction pathways. Nutr. Cancer 2007a, 58, 162-170.
12. Chen, J., Wang, L., Thompson, L. U., Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett. 2006, 234,168-175.
13. Chen, J., Stavro, P. M., Thompson, L. U., Dietary flaxseed inhibits breast cancer growth and metastasis and down-regulates expression of the insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 2002, 43, 187-192.
14. Thompson, L. U., Chen, J. M., Li, T., Stasser-Weippkl, K., Goss, P. E., Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 2005, 11,3828-3835.
15. Boon, H. S., Olatunde, F., Zick, S. M., Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007, 7, 4-10.
16. Rickard, S. E., Orcheson, L. J., Seidl, M. M., Luyengi, L. et al., Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J. Nutr. 1996, 126, 2012-2019.
17. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
18. Allred, D. C., Harvey, J. M., Berardo, M., Clark, G. M., Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 1998, 11, 155-168.
19. Singh, M. N., Stringfellow, H. F., Paraskevaidis, E., Martin-Hirsch, P. L., Martin, F. L., Tamoxifen: important considerations of a multi-functional compound with organ-specific properties. Cancer Treat. Rev. 2007, 33, 91-100.
20. Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C. et al., Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst. 2003, 95, 353-361.
21. Adlercreutz, H., Lignans and human health. Crit. Rev. Clin. Lab Sci. 2007, 44, 483-525.
22. Song, R. X., Fan, P., Yue, W., Chen, Y., Santen, R. J., Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer. Endocr. Relat. Cancer 2006, 13, S3-S13.
23. Cantley, L. C., The phosphoinositide 3-kinase pathway. Science 2002, 296, 1655-1657.
24. Massarweh, S., Osborne, C. K., Creighton, C. J., Qin, L. et al., Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res. 2008, 68, 826-833.
25. Dhingra, K., Antiestrogens--tamoxifen, SERMs and beyond. Invest. New Drugs 1999, 17, 285-311.
26. Maor, S., Mayer, D., Yarden, R. I., Lee, A. V. et al., Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J. Endocrinol. 2006, 191, 605-612.
27. Rickard, S. E., Yuan, Y. V., Thompson, L. U., Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett. 2000, 161, 47-55
28. Chen, J., Stavro, P. M., Thompson, L. U., Dietary flaxseed inhibits breast cancer growth and metastasis and down-regulates expression of epidermal growth factor receptor and insulin growth factor. Nutr. Cancer 2002, 43, 187-192
29. Bergman-Jungestrom, M., Thompson, L. U., Dabrosin, C., Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 2007, 13, 1061-1067
30. Dabrosin, C., Chen, J., Wang, L., Thompson, L. U., Flaxseed inhibits metastasis and decreases extracelular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 2002, 185, 31-37.
31. Thompson, L. U., in: Thompson, L. U., Ward, W. E. (Eds.), Food-drug Synergy and Safety, CRC Press, Boca Raton, FL 2006, pp. 147-169.
32. Escrich, E., Moral, R., Grau, L., Costa, I., Solanas, M., Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol. Nutr. Food Res. 2007, 51, 1279-1292.
33. Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M., Wolk, A., Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 2004,79,935-945.
34. Cheuk, B. L., Chew, S. B., Fiscus, R. R., Wong, P. Y., Cyclooxygenase-2 regulates apoptosis in rat epididymis through prostaglandin D2. Biol. Reprod. 2002, 66, 374-380.
35. DeGraffenried, L. A., Friedrichs, W. E., Fulcher, L., Fernandes, G. et al., Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann. Oncol. 2003, 14, 1051-1056.
36. Menéndez, J. A., Vázquez-Martín, A., Ropero, S., Colomer, R., Lupu, R., HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the ''fat features'' of the ''Mediterranean diet'' as an ''anti-HER2 cocktail''. Clin. Transl. Oncol. 2006, 8, 812-820.
37. Danbara, N., Yuri, T., Tsujita-Kyutoku, M., Sato, M. et al., Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. Nutr. Cancer 2004, 50, 71-79.
38. Bougnoux, P., Chajes, V., Alpha-linolenic acid and cancer., in: Thompson, L. U., Cunnane, S. C. (Eds.), Flaxseed in Human Nutrition, 2nd Edn., AOCS Press, Champaign, IL 2003, pp. 232-244.
39. Kitts, D. D., Yuan, Y. V., Wijewickreme, A. N., Thompson, L. U., Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cell. Biochem. 1999, 202, 91-100.
40. Thompson, L. U., Flaxseed, lignans, and cancer, in: Thompson, L. U., Cunnane, S. C. (Eds.), Flaxseed in Human Nutrition, 2nd Edn., AOCS Press, Champaign, IL 2003, pp. 194-222.
41. Albright, C. D., Salganik, R. I., Van Dyke, T., Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth and metastasis in transgenic mice. J. Nutr. 2004, 134,1139-1144.
42. Zabihi, S., Eriksson, U. J., Wentzel, P., Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod. Toxicol. 2007, 23, 486-498.
43. Takahashi, H., Kosaka, N., Nakagawa, S., Alpha-Tocopherol protects PC12 cells from hyperoxia-induced apoptosis. J. Neurosci. Res. 1998, 52, 184-191.